IQVIA Holdings, US46266C1053

IQVIA Holdings stock gains on earnings beat and higher guidance

Published on 09/07/2026 at 19:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

IQVIA Holdings stock is trading higher after a July 28, 2026 earnings beat, with FY 2026 EPS guidance at 12.800-13.000 and a $243.62 consensus target.

Modernes Pharmaforschungslabor mit Wissenschaftlern an Datenanalysesystemen
IQVIA Holdings betreibt ein modernes Pharmaforschungslabor US46266C1053 mit Wissenschaftlern an klinischen Datenanalysesystemen, Illustration mit AI erstellt.

IQVIA Holdings Inc. stock (US46266C1053) opened at USD 267.34 on Monday after a July 28, 2026 quarterly report that showed USD 3.15 EPS, up from USD 2.81 a year earlier. MarketBeat also said revenue reached USD 4.37 billion and FY 2026 EPS guidance was raised to 12.800-13.000.

Guidance stays in focus

The same report said the quarter beat the USD 3.03 EPS consensus by USD 0.12 and came in above the USD 4.30 billion revenue estimate by USD 70 million. Net margin was 8.10%, while return on equity reached 30.25% on the latest quarter.

MarketBeat reported a consensus rating of Moderate Buy and an average price target of USD 243.62, with Deutsche Bank at USD 240.00, Stifel at USD 276.00 and Morgan Stanley at USD 200.00 in notes dated July and June 2026.

Stock near the high

The stock's 12-month range ran from USD 154.50 to USD 271.80, and the USD 267.34 opening price left it close to the upper end of that band. Market cap was USD 44.00 billion in the same data set, alongside a P/E ratio of 33.17 and beta of 1.18.

What the quarter showed

The quarter's 8.7 percent revenue growth and the raised FY 2026 EPS guide point to a business that is still producing earnings leverage. For investors, the gap between the USD 267.34 trading level and the USD 243.62 consensus target now stands out more than the headline beat.

IQV platform mix

IQVIA's business still rests on clinical research, real world evidence and analytics tools for life sciences clients. The company's July 28, 2026 release framed that mix through revenue growth, margin expansion and a full-year EPS guide of 12.800-13.000.

Price and venue

IQVIA Holdings stock traded at USD 267.34 on the NYSE as of Monday, with the same data set showing a USD 44.00 billion market cap and a 12-month high of USD 271.80.

IQVIA Holdings stock at a glance

  • Company: IQVIA Holdings Inc.
  • ISIN: US46266C1053
  • Ticker: IQV
  • Trading venue: NYSE
  • Price (as of Monday): USD 267.34
  • Market capitalization: USD 44.00 billion
  • Sector / Industry: Health Care / Life Sciences Tools & Services
  • Index membership: S&P 500

More news and analyses on IQVIA Holdings stock

Disclaimer...

en | US46266C1053 | IQVIA HOLDINGS | boerse | 70065087 | bgmi